Rex American stock forecast
Rex American (RX3) Stock Forecast & Price Target
RX3 Analyst Ratings
RX3 Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Google Chemicals | TipRanks - Google | €46.63→€42.15 | buy | 20.42%Upside | Reiterated | 09/06/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | €44.84→€41.25 | buy | 17.86%Upside | Reiterated | 09/06/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | €46.63→€42.15 | buy | 20.42%Upside | Reiterated | 09/06/26 | ||
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | €44.84→€43.04 | buy | 22.98%Upside | Reiterated | 09/06/26 | ||
| Anthropic Chemicals | TipRanks - Anthropic | €43.94→€41.25 | buy | 17.86%Upside | Upgraded | 09/06/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | €45.73→€43.04 | buy | 22.98%Upside | Reiterated | 09/06/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Google ChemicalsTipRanks - Google | BuyReiterated€46.63→€42.15 | 09/06/26 | 20.42%Upside | ||
| OpenAI - Gpt-5.6SolTipRanks - OpenAI | BuyReiterated€44.84→€41.25 | 09/06/26 | 17.86%Upside | ||
| DeepSeek - V4ProTipRanks - DeepSeek | BuyReiterated€46.63→€42.15 | 09/06/26 | 20.42%Upside | ||
| PerPlexity - SonarReasoningProTipRanks - PerPlexity | BuyReiterated€44.84→€43.04 | 09/06/26 | 22.98%Upside | ||
| Anthropic ChemicalsTipRanks - Anthropic | BuyUpgraded€43.94→€41.25 | 09/06/26 | 17.86%Upside | ||
| xAI - Grok-4.3TipRanks - xAI | BuyReiterated€45.73→€43.04 | 09/06/26 | 22.98%Upside |
Best Analysts Covering Rex American
Copying Anthropic Chemicals's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -5.00% per trade.
Copying Anthropic Chemicals's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -5.00% per trade.
Copying Anthropic Chemicals's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -5.00% per trade.
RX3 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, RX3 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RX3 average Analyst price target in the past 3 months is ―.
RX3 Financial Forecast
RX3 Earnings Forecast
Next quarter’s earnings estimate for RX3 is EUR 0.96 with a range of ― to ―. The previous quarter’s EPS was EUR 0.96. Its overall industry beat the EPS estimate 45.00% of the time in the past 12 months.
RX3 Sales Forecast
Next quarter’s sales forecast for RX3 is EUR 169.49M with a range of ― to ―. The previous quarter’s sales results were EUR 169.49M. Its overall industry beat sales estimates 58.40% of the time in the past 12 months.
